Testosterone Lawsuit – News

Prescription low-T Supplement Lawsuit News

U.S. jury orders AbbVie to pay $3 million in AndroGel retrial

03/26/2018
A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.

READ MORE at Reuters

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

10/05/2017
A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff’s lawyer said in a statement.

READ MORE at Reuters

With new testosterone data, AbbVie's AndroGel faces more questions about heart risks

02/21/2017
AbbVie’s former blockbuster testosterone-replacement treatment AndroGel will be at the center of a class action lawsuit set to go to trial this year, alleging, in short, that previously healthy men suffered heart attacks and other side effects after taking the product.

READ MORE at FiercePharma

877-539-1539

For a FREE, no-obligation case evaluation, call now at 877-539-1539 or complete our form.

Your name:
Your contact information
Best time to reach you:

*By submitting this form, I am granting permission to be contacted via phone, email, text or any other means. I am also confirming that I understand that no attorney-client relationship exists without a specific written retainer agreement between myself and a law firm.